{
  "paper_id": "PMC9798677",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798677/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Flow diagram summarizing the pooled analysis phases",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb01015521cb/12885_2022_10471_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb01015521cb/12885_2022_10471_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb01015521cb/12885_2022_10471_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb01015521cb/12885_2022_10471_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb01015521cb/12885_2022_10471_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9798677/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb01015521cb/12885_2022_10471_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2.",
      "caption": "The association between eczema and brain cancer risk. A Forest plot of the estimated effects of eczema on brain cancer risk. B Sensitivity analysis conducted by recalculating the pooled results of the primary analysis following the exclusion of one study per iteration. C Begg’s and Egger’s tests indicate the lack of publication bias among such studies. D Subgroup analysis of the estimated effects of eczema on brain cancer risk. CI, Confidence interval; ES, Effect size",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/a4105e1d21d8/12885_2022_10471_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/a4105e1d21d8/12885_2022_10471_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/a4105e1d21d8/12885_2022_10471_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/a4105e1d21d8/12885_2022_10471_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/a4105e1d21d8/12885_2022_10471_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9798677/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/a4105e1d21d8/12885_2022_10471_Fig2_HTML.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Fig. 3.",
      "caption": "The association between eczema and glioma risk. A Forest plot of the estimated effects of eczema on glioma risk. B Sensitivity analysis. C Subgroup analysis of the estimated effects of eczema on glioma risk. D Begg’s and Egger’s tests indicate the lack of publication bias among such studies. CI, Confidence interval; ES, Effect size",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/98d6476e8895/12885_2022_10471_Fig3_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/98d6476e8895/12885_2022_10471_Fig3_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/98d6476e8895/12885_2022_10471_Fig3_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/98d6476e8895/12885_2022_10471_Fig3_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/98d6476e8895/12885_2022_10471_Fig3_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9798677/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/98d6476e8895/12885_2022_10471_Fig3_HTML.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Fig. 4.",
      "caption": "The association between eczema and meningioma risk. A Forest plot of the estimated effects of eczema on meningioma risk. B Sensitivity analysis. CI, Confidence interval",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb936aa4df4a/12885_2022_10471_Fig4_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb936aa4df4a/12885_2022_10471_Fig4_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb936aa4df4a/12885_2022_10471_Fig4_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb936aa4df4a/12885_2022_10471_Fig4_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb936aa4df4a/12885_2022_10471_Fig4_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9798677/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/eb936aa4df4a/12885_2022_10471_Fig4_HTML.jpg"
    },
    "figure_5": {
      "figure_number": "Figure 5",
      "title": "Fig. 5.",
      "caption": "Forest plot of the estimated effects of eczema on acoustic neuroma risk. Confidence interval",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/9aff8774fa62/12885_2022_10471_Fig5_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/9aff8774fa62/12885_2022_10471_Fig5_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/9aff8774fa62/12885_2022_10471_Fig5_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/9aff8774fa62/12885_2022_10471_Fig5_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig5",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/9aff8774fa62/12885_2022_10471_Fig5_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9798677/images/figure_5.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/9798677/9aff8774fa62/12885_2022_10471_Fig5_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Basic characteristics of the included studies\n\n\nStudy, year\nStudy design\nRegion\nCancer\nSample size\nCases\nControls\nAge range\nDate range\nNOS score\n\n\n\nRyan, 1992 [16]\nCase-control\nAustralia\nGlioma\n527\n110\n417\n25–74\n1987.02–1990.03\n7\n\n\nCicuttini, 1997 [17]\nCase-control\nAustralia\nGlioma\n838\n416\n422\n20–70\n1987.7–1992.10\n8\n\n\nSchlehofer, 1999(M) [18]\nCase-control\nOther\nMeningioma\n1454\n331\n1123\n20–80\n1980–1991\n6\n\n\nSchlehofer, 1999(G) [18]\nCase-control\nOther\nGlioma\n3165\n1178\n1987\n20–80\n1980–1991\n6\n\n\nBrenner, 2002 [19]\nCase-control\nAmerica\nCNS tumors\n1288\n489\n799\n18–90\n1994.6–1988.8\n7\n\n\nSchwartzbaum, 2003(G) [20]\nCohort\nEurope\nGlioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2003(M) [20]\nCohort\nEurope\nMeningioma\n14,535\nNA\nNA\n42–81\nNA\n9\n\n\nSchwartzbaum, 2005 [21]\nCase-control\nEurope\nGlioma\n806\n173\n633\n43–62\nNA\n8\n\n\nSchoemaker, 2006 [22]\nCase-control\nEurope\nGlioma\n2681\n965\n1716\n18–59\n2000–2004\n8\n\n\nSchoemaker, 2007 [23]\nCase-control\nEurope\nMeningioma\n2191\n475\n1716\n18–69\n2001–2004\n7\n\n\nWigertz, 2007 [24]\nCase-control\nEurope\nCNS tumors\n4836\n1527\n3309\n≥18\n2000.9–2004.2\n8\n\n\nHarding, 2008 [25]\nCase-control\nEurope\nCNS tumors\n6867\n575\n6292\n2–15\n1991–1996\n8\n\n\nBerg-Beckhoff, 2009(G) [26]\nCase-control\nEurope\nGlioma\n1098\n366\n732\n30–69\n2000.11–2003.11\n8\n\n\nBerg-Beckhoff, 2009(M) [26]\nCase-control\nEurope\nMeningioma\n1143\n381\n762\n30–69\n2000.11–2003.11\n8\n\n\nIl’yasova, 2009 [27]\nCase-control\nAmerica\nGlioma\n565\n388\n177\n≥18\n2003.8–2008.4\n7\n\n\nSchoemaker, 2009 [28]\nCase-control\nEurope\nPituitary tumor\n929\n299\n630\n18–59\n2000.12–2005.2\n8\n\n\nRoncarolo, 2012 [29]\nCase-control\nAmerica\nCNS tumors\n16\n6\n10\n0–14\n1980–1999\n9\n\n\nTurner, 2013 [30]\nCase-control\nOther\nAcoustic neuroma\n199\n34\n165\n30–59\n2000-–004\n8\n\n\nAmirian, 2016 [31]\nCase-control\nOther\nGlioma\n8019\n4270\n3749\n18–80\nNA\n7\n\n\nLupatsch, 2018 [32]\nCase-control\nEurope\nCNS tumors\n3188\n469\n2719\n1–14\nNA\n8\n\n\nPouchieu, 2018(G) [33]\nCase-control\nEurope\nGlioma\n777\n253\n524\n≥16\n2004–2010\n8\n\n\nPouchieu, 2018(M) [33]\nCase-control\nEurope\nMeningioma\n627\n206\n421\n≥16\n2004–2010\n8\n\n\nD’Arcy, 2019 [34]\nCase-control\nAmerica\nCNS tumors\n1,844,575\n15,205\n100,000\n66–99\n1992–2013\n7\n\n\nMansfield, 2020(U) [35]\nCohort\nEurope\nCNS tumors\n2,711,745\nNA\nNA\n24.9–60.7\n1998.2–2016.3\n8\n\n\nMansfield, 2020(D) [35]\nCohort\nEurope\nCNS tumors\n490,618\nNA\nNA\n1.7–21.1\n1982.2–2016.6\n8\n\n\n\nOpen in a new tab\nCNS Central nervous system, NA not mentioned, NOS Newcastle-Ottawa ScaleEczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After assessing the full text of the remaining articles and relevant articles in their bibliographies, 20 studies [16–35] were included (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Eczema and brain cancer risk\nEczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "CI, Confidence interval; ES, Effect sizeNext, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Eczema was significantly associated with a decreased brain cancer risk in the analysis with all 20 studies [16–35] (OR, 0.82; 95% CI, 0.77–0.87; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Insignificant heterogeneity greatly enhanced the reliability of the results (P = 0.004, I2 = 48.1%; Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis indicated that excluding each study in turn all studies were distributed between the upper and lower 95% CIs with the estimation line, and excluding any one study did not alter the overall combined results (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Publication bias, assessed by Begg’s rank correlation and Egger’s linear regression, did not identify publication bias among the studies (Begg’s: P > |z| = 0.362; Egger’s: P = 0.183, 95% CI: − 1.900–0.384; Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Next, to test this hypothesis that the brain cancer risk might be influenced in different aged eczema patients, subgroup analyses based on age were performed; we identified a strong association between eczema and brain cancer risk in those aged over 16 years (OR, 0.79; 95% CI, 0.71–0.88) but no association for those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11; Fig. 2D).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Eczema and glioma risk\nEczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Eczema significantly decreased the glioma risk (OR, 0.77; 95% CI, 0.66–0.89; Fig. 3A); the analysis included 16 studies [16–22, 24–27, 29–31, 33, 34].",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The sensitivity analysis confirmed that the meta-analysis was robust (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, significant heterogeneity was observed (P = 0.001, I2 = 59.6%; Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, the relationship between eczema and glioma risk was statistically insignificant for Australians (OR, 0.53; 95% CI, 0.14–2.02; I2 = 68.7%) and Americans (OR, 1.01; 95% CI, 0.69–1.46; I2 = 41.5%) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Publication bias was not observed among the studies (Begg’s: P > |z| = 0.685; Egger’s: P = 0.344, 95% CI: − 2.635–0.983; Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Heterogeneity was not observed (P = 0.996, I2 = 0.0%; Fig. 4A), and excluding individual studies did not alter the overall results (Fig. 4B), indicating that these results were reliable.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "There was no heterogeneity (P = 0.366, I2 = 0.0%; Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 5,
    "claims_count": 134,
    "images_downloaded": 5,
    "tables_filtered": 48
  }
}